IL4RPep-1
IL4RPep-1 is a peptide that can specifically target atherosclerotic plaque, and its target is IL-4 receptor. IL4RPep-1 exhibits good plaque targeting and is not enriched in normal tissues. IL4RPep-1 has potential application as a targeting delivery system or molecular imaging probe for atherosclerosis research[1].
Product Specifications
CAS Number
1900734-29-3
UNSPSC
12352209
Target
Interleukin Related
Related Pathways
Immunology/Inflammation
Field of Research
Cardiovascular Disease
Smiles
O=C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(C)C)C(N[C@@H](CC(O)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@H]1CC(N)=O)=O)=O)=O)=O)=O)=O)[C@H](CSSC[C@@H](C(O)=O)NC1=O)N
Molecular Formula
C44H80N20O13S2
Molecular Weight
1161.36
References & Citations
[1]Hong HY, et al. Phage display selection of peptides that home to atherosclerotic plaques: IL-4 receptor as a candidate target in atherosclerosis. J Cell Mol Med. 2008 Oct;12 (5B) :2003-14.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
IL-4
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1475553-01 0.5 mg (E-Coli)
Recombinant Anopheles gambiae WSCD family member AGAP003962 (AGAP003962), partial
Sign In for Pricing
View Details MBS1475553-02 0.05 mg (Baculovirus)
Recombinant Anopheles gambiae WSCD family member AGAP003962 (AGAP003962), partial
Sign In for Pricing
View Details MBS1475553-03 0.5 mg (Yeast)
Recombinant Anopheles gambiae WSCD family member AGAP003962 (AGAP003962), partial
Sign In for Pricing
View Details MBS1475553-04 0.05 mg (Mammalian-Cell)
Recombinant Anopheles gambiae WSCD family member AGAP003962 (AGAP003962), partial
Sign In for Pricing
View Details MBS1475553-05 1 mg (E-Coli)
Recombinant Anopheles gambiae WSCD family member AGAP003962 (AGAP003962), partial
Sign In for Pricing
View Details